ReviewCurrent research in toxicology2026
Mechanisms of neurotoxicity of fluoride or aluminum: implications for neurodegenerative disease risk.
Review in Current research in toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Fluoride and aluminum are two naturally abundant elements with widespread industrial uses. Fluoride is also added to community water supplies as a public health intervention for dental cavity prevention. However, findings from animal studies show potential links of fluoride and aluminum exposure with neurodegenerative disease risk, particularly at high exposure levels. This review uniquely examines neurochemical and neurobiological impacts of fluoride and aluminum exposure as well as whether these processes may increase the risk of common and rare neurodegenerative diseases, including dementia, Parkinson's Disease, and motor neuron disease. Fluoride and aluminum can cross the blood-brain barrier and accumulate in neural tissue, where they can interact to produce neurotoxic effects. Chronic exposure to fluoride and aluminum can cause oxidative stress, mitochondrial dysfunction, brain inflammation, and disruption of essential ions. These effects can contribute to impaired nerve signaling, cell damage, and protein aggregation-key factors in neurodegeneration. Co-exposure to aluminum-fluoride complexes may worsen these effects by increasing amyloid buildup and causing nerve cell death, although more research on aluminum-fluoride interactions is needed. Additionally, many animal studies include relatively high fluoride or aluminum exposure levels, and epidemiological human data are scarce, particularly for less common neurodegenerative diseases. Moreover, these studies often rely on ecological or occupational exposure measures rather than individual biomarkers. Findings of this narrative review underscore the need for methodologically rigorous longitudinal human studies on fluoride, aluminum and neurodegenerative disease risk, particularly given the mechanistic basis for these potential associations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.